Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Incanthera (R&D) Ltd. maintains a highly concentrated patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company currently faces 1 pending office action, which constitutes the total volume of its active prosecution. This workload is distributed across 1 distinct examiner and 1 distinct art unit, suggesting a narrow and specialized scope of inquiry from the patent office at this time. The lack of broader distribution across multiple units indicates that the portfolio's current legal challenges are confined to a specific technical niche.
The busiest examiner identified in the data is SONG, JIANFENG, who is currently handling 1 busiest examiner pending office action. This 1 pending office action represents the entirety of the company's active interactions with the patent office. For practitioners, this means that the prosecution success for the portfolio presently hinges on the specific preferences and historical patterns of this 1 distinct examiner. The alignment of 1 distinct examiner with 1 distinct art unit ensures that the prosecution remains focused, though it also limits the opportunity for varied examiner perspectives across the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SONG, JIANFENG | 1 | 56.3% | +33.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018215 | TOPICAL FORMULATION | SONG, JIANFENG | 79d |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18018215 | TOPICAL FORMULATION | SONG, JIANFENG | 1613 | §103 | Final Rejection | 79d | Pending | Jan 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial